Complications of treatment
Free radicals and antioxidants in chemotherapyinduced toxicity

https://doi.org/10.1016/S0305-7372(97)90012-8Get rights and content

First page preview

First page preview
Click to open first page preview

References (264)

  • T.C. Carmine et al.

    Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic management

    Cancer Lett.

    (1995)
  • B. Halliwell et al.

    Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. Therapeutic implications for treatment with oxidant-generating drugs

    FEBS Lett.

    (1988)
  • V.R. Gordeuk et al.

    Bleomycin-reactive iron in patients with acute nonlymphocytic leukemia

    FEBS Lett.

    (1992)
  • H.G. Keizer et al.

    Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity

    Pharmacol. Ther.

    (1990)
  • K. Shimpo et al.

    Ascorbic acid and adriamycin toxicity

    Am. J. Clin. Nutr.

    (1991)
  • K. Sue et al.

    Combined effects of vitamin E (alpha-tocopherol) and cisplatin on the growth of murine neuroblastoma in vivo

    Eur. J. Cancer Clin. Oncol.

    (1988)
  • J.H. Doroshow

    Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents

    Biochem. Biophys. Res. Commun.

    (1986)
  • S. Nyayapati et al.

    Depletion of cellular iron by BPS and ascorbate: effect on toxicity of adriamycin

    Free Radic. Biol. Med.

    (1996)
  • H. Masuda et al.

    Cisplatin generates superoxide anion by interaction with DNA in a cell-free system

    Biochem. Biophys. Res. Commun.

    (1994)
  • W.W. Wells et al.

    Interactions of platinum complexes with thioltransferase (glutaredoxin), in vitro

    Biochem. Biophys. Res. Commun.

    (1991)
  • A. Sodhi et al.

    Increased release of hydrogen peroxide (H2O2) and superoxide anion (O2) by murine macrophages in vitro after cis-platin treatment

    Int. J. Immunopharmacol.

    (1986)
  • E.G. Mimnaugh et al.

    The effects of alphatocopherol on the toxicity, disposition, and metabolism of adriamycin in mice

    Toxicol. Appl. Pharmacol.

    (1979)
  • J. Milei et al.

    Amelioration of adriamycin-induced cardiotoxicity in rabbits by prenylamine and vitamins A and E

    Am. Heart J.

    (1986)
  • T. Facchinetti et al.

    The influence of selenium intake on chronic adriamycin toxicity and lipid peroxidation in rats

    Toxicol. Lett.

    (1983)
  • A. Jotti et al.

    Protective effect of dietary selenium supplementation on delayed cardiotoxicity of adriamycin in rat: is PHGPX but not GPX involved?

    Free Radic. Biol. Med.

    (1994)
  • D.V. Unverferth et al.

    Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs

    Am. J. Cardiol.

    (1985)
  • R.W. Freeman et al.

    Effect of sulfhydryl-containing compounds on the antitumor effects of adriamycin

    Toxicol. Appl. Pharmacol.

    (1980)
  • G. Solaini et al.

    Protective effect of endogenous coenzyme Q on both lipid peroxidation and respiratory chain inactivation induced by an adriamycin-iron complex

    Biochem. Biophys. Res. Commun.

    (1987)
  • K. Folkers et al.

    Inhibition by adriamycin of the mitochondrial biosynthesis of coenzyme Q10 and implication for the cardiotoxicity of adriamycin in cancer patients

    Biochem. Biophys. Res. Commun.

    (1977)
  • Y. Iwamoto et al.

    Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity

    Biochem. Biophys. Res. Commun.

    (1974)
  • H. Ohhara et al.

    A protective effect of coenzyme Q10 on the adriamycin-induced cardiotoxicity in the isolated perfused rat heart

    J. Mol. Cell. Cardiol.

    (1981)
  • B. Halliwell et al.

    Free Radicals in Biology and Medicine

  • B. Halliwell et al.

    Free Radicals in Biology and Medicine

  • B.A. Arrick et al.

    Glutathione metabolism as a determinant of therapeutic efficacy: a review

    Cancer Res.

    (1984)
  • J. Hidalgo et al.

    Metallothionein response to stress in rats: role in free radical scavanging

    Am. J. Physiol.

    (1988)
  • N. Iwai et al.

    Metallothionein induction by sodium selenite at two different ambient temperatures in mice

    Arch. Toxicol.

    (1988)
  • Vitamin C can promote selenium utilization

    Nutr. Rev.

    (1990)
  • S.J.S. Flora et al.

    Preventive and therapeutic effects of thiamine, ascorbic acid and their combination in lead intoxication

    Acta Pharmacol. Toxicol.

    (1986)
  • B. Leibovitz et al.

    Dietary supplements of vitamin E, β-carotene, coenzyme Q10 and selenium protect tissues against lipid peroxidation in rat tissue slices

    J. Nutr.

    (1989)
  • G.W. Comstock et al.

    Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites

    Am. J. Epidemiol.

    (1992)
  • P.A. Van den Brandt et al.

    A prospective cohort study on selenium status and the risk of lung cancer

    Cancer Res.

    (1993)
  • R.M. Bostick et al.

    Reduced risk of colon cancer with high intake of vitamin E: the Iowa women's health study

    Cancer Res.

    (1993)
  • K. Yang et al.

    The relationship between nutritional antioxidants and serum lipid peroxides in cancer patients

    In Vivo

    (1989)
  • M.P. Look et al.

    Lipid peroxides in the polychemotherapy of cancer patients

    Chemotherapy

    (1994)
  • S. Subramaniam et al.

    Oxidant and antioxidant levels in the erythrocytes of breast cancer patients treated with CMF

    Med. Sci. Res.

    (1993)
  • M. Faber et al.

    Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study

    Biol. Trace Elem. Res.

    (1995)
  • M. Durken et al.

    Deteriorating free radical-trapping capacity and antioxidant status in plasma during bone marrow transplantation

    Bone Marrow Transplant.

    (1995)
  • C. Ladner et al.

    Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen

    Cancer Chemother. Pharmacol.

    (1989)
  • M. Satoh et al.

    Effect of coadministration of selenite on the toxicity and antitomor activity of cis-diamminedichloroplatinum(II) given repeatedly to mice

    Cancer Chemother. Pharmacol.

    (1992)
  • G.S. Baldew et al.

    Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen

    Cancer Res.

    (1990)
  • Cited by (274)

    • Protection against chemotherapy- and radiotherapy-induced side effects: A review based on the mechanisms and therapeutic opportunities of phytochemicals

      2021, Phytomedicine
      Citation Excerpt :

      As many anticancer drugs target DNA in proliferating cells, their side effects are primarily manifested in tissues with high-proliferative cells such as bone marrow and gastrointestinal tract, and result in gastrointestinal toxicity, myelosuppression, and immunosuppression (Hurley, 2002). Further, chemotherapeutic drugs and irradiation are known to induce oxidative stress and inflammatory response, and they are closely associated with chromosomal instability and secondary tumor generation (Vyas et al., 2014; Weijl et al., 1997). Therefore, a better understanding of the mechanisms that underlie the induction of the side effects can facilitate the design of supportive or adjuvant therapies for combating them.

    View all citing articles on Scopus
    View full text